表紙
市場調査レポート - 240574

非アルコール性脂肪性肝炎:世界の治験動向

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015

発行 GlobalData
出版日 ページ情報 英文 93 Pages
電子版即納可
価格
Back to Top
非アルコール性脂肪性肝炎:世界の治験動向 Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015
出版日: 2015年05月20日 ページ情報: 英文 93 Pages
概要

当レポートでは、非アルコール性脂肪性肝炎に関する臨床研究の最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 非アルコール性脂肪性肝炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:胃腸疾患治療薬の治験における非アルコール性脂肪性肝炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:胃腸疾患治療薬の治験における非アルコール性脂肪性肝炎の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

非アルコール性脂肪性肝炎治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Genextra S.p.a.
    • Genfit SA
    • Cempra, Inc.
    • Raptor Pharmaceuticals Corp.
    • Nimbus Therapeutics, LLC
    • Immuron Limited
    • Gilead Sciences, Inc.
    • Galmed International Ltd.
    • Galectin Therapeutics, Inc.
    • DURECT Corporation
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Tehran University of Medical Sciences
    • University of California, San Diego
    • National Nutrition and Food Technology Research Institute
    • 横浜市立大学
    • Bambino Gesu Hospital and Research Institute
    • Ghent University Hospital
    • Gunma Liver Study Group
    • Hadassah Medical Organization
    • Hiroshima University Hospital

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Alcoholic Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Non-Alcoholic Steatohepatitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Non-Alcoholic Steatohepatitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Non-Alcoholic Steatohepatitis
      • May 04, 2015: Islet Sciences Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH
      • Apr 23, 2015: Diabetes drug shows promise in the treatment of non-alcoholic steatohepatitis
      • Apr 23, 2015: Intercept Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution and Cirrhosis Prevention in High-Risk NASH Patients
      • Apr 23, 2015: Conatus Clinical Results at EASL Meeting Support Emricasan Registration Pathway in NASH
      • Apr 21, 2015: Nimbus Therapeutics Announces Initiation of Clinical Studies for ACC Inhibitor
      • Apr 21, 2015: Upcoming AACR and EASL poster presentations support Nimbus' novel, liver-directed approach to allosteric ACC inhibition across liver disease spectrum, including NASH and HCC
      • Apr 20, 2015: NGM Biopharmaceuticals to Present New Data on NGM282 at the European Association for the Study of the Liver International Liver Congress 2015
      • Apr 08, 2015: Tobira Therapeutics Highlights Presentations at The International Liver Congress 2015
      • Apr 08, 2015: Conatus Pharmaceuticals to Present Three Emricasan Clinical Results Posters at EASL Meeting
      • Mar 30, 2015: DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study
      • Mar 26, 2015: Conatus Announces Successful Top-Line Results From NAFLD/NASH Clinical Trial of Emricasan
      • Mar 20, 2015: Intercept Announces New Data Analyses From FLINT Trial of Obeticholic Acid in NASH
      • Mar 18, 2015: Metabolic Solutions Development Company Highlights Plans for MSDC-0602 in NASH and Polycystic Kidney Disease
      • Mar 12, 2015: Galectin Therapeutics Engages PPD to Conduct GR-MD-02 Phase 2 Trial in NASH, Submits Special Protocol Assessment to FDA
      • Mar 09, 2015: Islet Sciences COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)
      • Mar 09, 2015: Galmed Pharmaceuticals Announces the Beginning of Enrollment in its Phase IIb ARREST Trial for the Treatment of NASH, as well as the Expansion of the Study to the United States
      • Feb 25, 2015: MediciNova's MN-001 (tipelukast) NASH with Advanced Fibrosis Abstract Accepted for Presentation at the AASLD and Industry Colloquium: Novel Targets and Therapies in Liver Disease in Durham, North Carolina
      • Feb 24, 2015: Galectin Therapeutics Announces Details of the Design of Its Phase 2 Program With GR-MD-02
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Genextra S.p.a.
      • Clinical Trial Overview of Genextra S.p.a.
      • Genfit SA
      • Clinical Trial Overview of Genfit SA
      • Cempra, Inc.
      • Clinical Trial Overview of Cempra, Inc.
      • Raptor Pharmaceuticals Corp.
      • Clinical Trial Overview of Raptor Pharmaceuticals Corp.
      • Nimbus Therapeutics, LLC
      • Clinical Trial Overview of Nimbus Therapeutics, LLC
      • Immuron Limited
      • Clinical Trial Overview of Immuron Limited
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Galmed International Ltd.
      • Clinical Trial Overview of Galmed International Ltd.
      • Galectin Therapeutics, Inc.
      • Clinical Trial Overview of Galectin Therapeutics, Inc.
      • DURECT Corporation
      • Clinical Trial Overview of DURECT Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • National Nutrition and Food Technology Research Institute
      • Clinical Trial Overview of National Nutrition and Food Technology Research Institute
      • Yokohama City University
      • Clinical Trial Overview of Yokohama City University
      • Bambino Gesu Hospital and Research Institute
      • Clinical Trial Overview of Bambino Gesu Hospital and Research Institute
      • Ghent University Hospital
      • Clinical Trial Overview of Ghent University Hospital
      • Gunma Liver Study Group
      • Clinical Trial Overview of Gunma Liver Study Group
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nimbus Therapeutics, LLC, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immuron Limited, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galectin Therapeutics, Inc., 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DURECT Corporation, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Nutrition and Food Technology Research Institute, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bambino Gesu Hospital and Research Institute, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gunma Liver Study Group, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015*

List of Figures

  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Non-Alcoholic Steatohepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top